Our analyses demonstrate that AR is protective in ccRCC and that inhibition of androgen signaling could contribute to progression of disease, suggesting that the role of AR in breast cancer might be different from that in colon cancer and RCC. This evidence concerns the gene AR and renal cell carcinoma.